Nano-adjuvants are being used in several types of vaccines, including those for infectious diseases like COVID-19. The use of lipid nanoparticles in mRNA vaccines has been a significant breakthrough, demonstrating the potential of nanotechnology in vaccine development. Additionally, research is ongoing to develop nano-adjuvants for cancer immunotherapy and other chronic diseases.
